Experiments have revealed that polymorphisms in the non-coding regions of eNOS may alter eNOS expression and thus cause a decrease in NO synthesis [13], which may predispose patients to hypertension, vasospasm and atherosclerosis. The gene discussed is NOS3; the disease is Hypertension.